Log In
BCIQ
Print this Print this
 

APX005M

  Manage Alerts
Collapse Summary General Information
Company Apexigen Inc.
DescriptionAgonistic humanized mAb that targets CD40
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today